We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
No training was provided to the executive assistant who had been conducting quality audits at the firm’s manufacturing facility, an FDA investigator said. Read More
Earlier this year, representatives of 36 conservative groups sent a letter to Congress urging lawmakers to block the return of the device tax on Jan. 1. Read More
Royal Philips agreed to enter into a consent decree with the U.S. Department of Justice to suspend production of its automated external defibrillators at two of its U.S. manufacturing sites. Read More